STUDY OBJECTIVE: We report the first teenage case of @entity3652 -induced @entity6659 . CASE SUMMARY: The @entity1 was an 18-year-old @entity1 with @entity7025 undergoing an external carotid to internal carotid bypass and given a low-dose @entity3652 infusion. After approximately 2 hours in the supine position, with 0.5 Minimum Alveolar Concentration (MAC) of @entity2614 , a @entity1875 infusion at 50  g/kg/min, a @entity1937 infusion at 0.5  g/kg/min, and a @entity3652 infusion at a dose of 10  g/kg/min, this @entity1 had an excessive urine output. Initially, the Foley catheter contained 50 mL of urine. She was given 1500 mL of crystalloid during the case but produced 2700 mL of urine output. Increasing urine output was noted 1 hour into the procedure around the time that the @entity1 experienced a 2-minute Cushing-like response characterized by @entity1168 and @entity101 . Several I-Stat samples revealed a worsening @entity3489 . The decision was made to check the urine osmolality and treat the @entity1 with 4  g of desmopressin (DDAVP). Urine output began to slow down to a normal rate of 2 mg/kg/h, as the @entity1 was transferred from the operating room to the computed tomographic (CT) scanning room for a CT and CT angiogram; both were unremarkable. The neurosurgery team waited until the next day to complete the procedure. The procedure was completed successfully and uneventfully the next day without a @entity3652 infusion as part of the general anesthetic plan. DISCUSSION: The Naranjo @entity137 score of 4 suggested a possible relationship between the @entity1 's @entity3652 infusion and subsequent central @entity2010 . The 2 previous cases on this topic have suggested that @entity3652 , as an @entity3391 receptor antagonist, inhibits @entity1951 release in the neurohypophysis. CONCLUSION: Urine output, urine osmolarity, and serum osmolarity should be monitored in @entity1 given @entity3652 anesthetic; desmopressin should be present to prevent dangerous long-term sequela.

A case of central @entity2010 after XXXX infusion during an external to internal carotid artery bypass.

@entity1 :: ('9606', 'Species') :: ['woman', 'patients', 'patient'] @entity137 :: ('MESH:D064420', 'Disease') :: ['Adverse Drug Reaction'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity3391 :: ('D016202', 'Chemical') :: ['N-methyl-d-aspartate'] @entity1951 :: ('MESH:D014667', 'Chemical') :: ['vasopressin'] @entity3652 :: ('MESH:D007649', 'Chemical') :: ['ketamine'] @entity2010 :: ('MESH:D003919', 'Disease') :: ['diabetes insipidus'] @entity7025 :: ('MESH:D009072', 'Disease') :: ['moyamoya disease'] @entity1875 :: ('MESH:D015742', 'Chemical') :: ['propofol'] @entity2614 :: ('MESH:C009250', 'Chemical') :: ['sevoflurane'] @entity6659 :: ('MESH:D020790', 'Disease') :: ['transient central diabetes insipidus'] @entity1168 :: ('MESH:D001919', 'Disease') :: ['bradycardia'] @entity3489 :: ('MESH:D006955', 'Disease') :: ['hypernatremia'] @entity1937 :: ('MESH:C071741', 'Chemical') :: ['remifentanil']
@entity3652 :: (MESH:D007649,Chemical) :: ['ketamine']
